Gabi Ahne

Scientist
Project Management GermanNetPaeT

Dr. Gabriele Ahne

Tel +49-9131-85 41748

gabriele.ahne@ikp-stuttgart.de

Major Projects

c4c/GermanNetPaeT (Project Management)
Kinderformularium.DE
KiDSafe (UAE-K)
CloSed (EU-FP7,Study Management)

Selected References

Ahne G, Nagel J, Franz AR, Neubert A, Schachtrup K, Helms S, Klammt S, Schwab M. Joint recommendations on cost calculation and estimation in paediatric clinical trials. Ger Med Sci. 2024 Apr 24;22:Doc04. DOI: 10.3205/000330

Neubert A, Toni I, König J, Malonga Makosi D, Mildenberger P, Romanos M, Bertsche A, Bertsche T, Dahlem P, Egberts K, Erdlenbruch B, Fekete S, Haug U, Horneff G, Hübler A, Kiess W, Neininger MP, Niehues T, Sachs B, Schettler KF, Schreeck F, Steimle T, Wenzl T, Wirth S, Zepp F, Schwab M, Urschitz MS, Rascher W; KiDSafe Consortium. A Complex Intervention to Prevent Medication-Related Hospital Admissions. Dtsch Arztebl Int.. 2023 Jun 23;120(25):425-431.

Schreeck F, Ahne G, Tremmel R, Schaeffeler E, Schwab M. Pharmacogenomics in pediatric medicine and drug development. Pharmacogenomics. 2022 Aug;23(13):709-712.

Eberl S, Ahne G, Toni I, Standing J, Neubert A. Safety of clonidine used for long-term sedation in paediatric intensive care: A systematic review. Br J Clin Pharmacol. 2021 Mar;87(3):785-805.

Egger T, Dormann H, Ahne G, Pahl A, Runge U, Azaz-Livshits T, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K. Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study. Drugs Aging. 2005;22(3):265-72.

Curriculum Vitae

Education and Professional Career

2021-present

Project Manager GermanNetPaeT, c4c (https://conect4children.org/ ) at IKP, Stuttgart (Prof. M. Schwab)

2017-present

Research Associate at Center for Paediatric Clinical Studies, University Hospital Erlangen (Prof. A. Neubert)

2016-2017

Pharmacovigilance Officer at CCS (Center for Clinical Studies), University Hospital Erlangen

2003-2016

Hospital Pharmacist at Waldkrankenhaus St. Marien, Erlangen

1996-2003

PhD-Thesis „Modification of opioid effects in humans using an experimental pain model“ (Prof. G. Kobal) and Postdoctoral research fellow „Drug Epidemiology (Prof K. Brune) at Friedrich-Alexander-University Erlangen-Nürnberg, Institute of Experimental and Clinical Pharmacology